Sequencing Insights into Targeted T Cell Engager Therapy
Targeted T cell therapies harness and redirect a patient’s own T cells toward cancer cells, offering a highly specific and powerful approach to cancer immunotherapy. We showcase how Novogene sequencing delivered high-resolution insight into therapy-induced remodeling of the tumor microenvironment during preclinical development.
• Understand the design and mechanism of action of targeted multispecific T cell engager therapies in glioblastoma. • Learn how advanced sequencing performed by Novogene can be applied to interrogate immune responses and tumor microenvironment remodeling. • Gain insight into how sequencing-driven analyses inform preclinical development and evaluation of targeted T cell immunotherapies.
Joseph Duffy — Graduate Student at Department of Neurological Surgery Northwestern University